Point-Of-Care Diagnostics 2.0: Beyond the Clinic

November 12, 2019 | State of the Market Report

Point-of-care diagnostics (POCDs) have been essential tools in the rapid detection of biomarkers and analytes, which facilitates better disease diagnosis, monitoring, and management. However, with some exceptions like the pregnancy test kit and glucose test strips, first-generation POCDs have traditionally been reliant on biomarkers that require specialized conditions and trained personnel to handle. First-generation POCDs also offer limited utility in the information they provide, and more follow-up tests are often needed to get more in-depth, actionable information. A new generation of POCDs is emerging that not only enhances what existing POCDs can do, but also offers new diagnostic modalities that are minimally invasive or non-invasive. In addition, POCD 2.0 increasingly allow the layperson to run tests at the convenience of his/her homes and get a rapid assessment, allowing follow-up steps to be taken to address any deviations. This report will assess the maturity of POCD 2.0 and how these diagnostics are playing a role not just in the clinic and in at-home-use for patients, but also among healthy consumers, offering predictive analytics that ensure consumers stay on a healthy path.

Coverage Areas

  • Consumer IoT
  • Digital Health and Wellness
  • Digital Transformation
  • Emerging Ecosystems in Agrifood and Health
  • Industrial Big Data and Analytics
  • Sensors

Table of Contents

  • Title page
  • Executive Summary
  • Introduction
  • State of Innovation Today
  • Point-Of-Care Diagnostics 2.0
  • Appendix

Lead Analyst

Nardev Ramanathan, Ph.D.
Analyst

Contributors

Shriram Ramanathan, Ph.D.
Jonathan Melnick, Ph.D.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978